a7fc482-53bc-5610-8cec-fa63290a1ca5

Property	Value
?:citation	<https://web.archive.org/web/20001206143300/https://www.fda.gov/cder/drug/infopage/ppa/default.htm?> <https://web.archive.org/web/20010107203100/https://www.fda.gov/cder/drug/infopage/ppa/qa.htm?> <https://web.archive.org/web/20010123220300/https://www.fda.gov/cder/drug/infopage/ppa/advisory.htm?> <https://web.archive.org/web/20011120081916/https://www.fda.gov/ohrms/dockets/ac/00/backgrd/3647b1_tab19.do?>
is ?:itemReviewed of	claimskg:claim_review/4b9753b6-fbf3-5c50-b664-cdd53250be91
?:keywords	claimskg:keyword/a4d5ccc8-2220-55d4-a5a0-bf6595464377 claimskg:keyword/a72c7dee-9a24-5b9b-aed9-5bcc8224647b claimskg:keyword/bf9c19d3-39ab-5bec-b625-dc56be2cc1e5
?:mentions	claimskg:mention/25b0c726-dc8f-5ea0-9479-c1842dabd5e7 claimskg:mention/93a10c8c-6098-51e1-9fd6-7270ec517bb5 claimskg:mention/bcd9a02e-18b7-5f59-a2c6-95ce108db216
?:text	Drug products containing PPA (phenylpropanolamine) were pulled from the market due to FDA concerns over a possible connection to strokes. (en)
rdf:type	<http://schema.org/CreativeWork>